Targeted disruption of β1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction

Cancer Cell

Volumn 6, Issue 2, 2004, Pages 159-170

  White, Donald E ^a,b   Kurpios, Natasza A ^a   Zuo, Dongmei ^b   Hassell, John A ^a   Blaess, Sandra ^c   Mueller, Ulrich ^d   Muller, William J ^b,e  

^a MCMASTER UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER MODEL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM TUMOR; FEMALE; GENE DISRUPTION; GENETIC RECOMBINATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSGENIC MOUSE; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; CELL TRANSFORMATION; GENE TARGETING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HISTOLOGY; HUMAN; METABOLISM; PATHOLOGY; UDDER;

ANIMALIA; MUS MUSCULUS;

BETA1 INTEGRIN; FOCAL ADHESION KINASE; FOCAL ADHESION KINASE 1; PROTEIN TYROSINE KINASE; PTK2 PROTEIN, HUMAN; PTK2 PROTEIN, MOUSE;

ANIMALS; ANTIGENS, CD29; BREAST NEOPLASMS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE TARGETING; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; PROTEIN-TYROSINE KINASES; TUMOR CELLS, CULTURED;

EID: 5144235557     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.06.025     Document Type: Article

References (52)

1. Adelsman M.A., McCarthy J.B., Shimizu Y. Stimulation of β1-integrin function by epidermal growth factor and heregulin-β has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase. Mol. Biol. Cell. 10:1999;2861-2878
2. Aguirre Ghiso J.A. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene. 21:2002;2513-2524
3. Ahmed N., Riley C., Oliva K., Stutt E., Rice G.E., Quinn M.A. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J. Pathol. 201:2003;229-237
4. Andrechek E.R., Hardy W.R., Siegel P.M., Rudnicki M.A., Cardiff R.D., Muller W.J. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc. Natl. Acad. Sci. USA. 97:2000;3444-3449
5. Bissell M.J., Radisky D.C., Rizki A., Weaver V.M., Petersen O.W. The organizing principle. Microenvironmental influences in the normal and malignant breast Differentiation. 70:2002;537-546
6. Cance W.G., Harris J.E., Iacocca M.V., Roche E., Yang X., Chang J., Simkins S., Xu L. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues. Correlation with preinvasive and invasive phenotypes Clin. Cancer Res. 6:2000;2417-2423
7. D'Amico M., Hulit J., Amanatullah D.F., Zafonte B.T., Albanese C., Bouzahzah B., Fu M., Augenlicht L.H., Donehower L.A., Takemaru K., et al. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3β and cAMP-responsive element-binding protein-dependent pathways. J. Biol. Chem. 275:2000;32649-32657
8. Dedhar S., Williams B., Hannigan G. Integrin-linked kinase (ILK). A regulator of integrin and growth-factor signalling Trends Cell Biol. 9:1999;319-323
9. Falcioni R., Antonini A., Nistico P., Di Stefano S., Crescenzi M., Natali P.G., Sacchi A. α6β4 and α6β1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp. Cell Res. 236:1997;76-85
10. Faraldo M.M., Deugnier M.A., Lukashev M., Thiery J.P., Glukhova M.A. Perturbation of β1-integrin function alters the development of murine mammary gland. EMBO J. 17:1998;2139-2147
11. Faraldo M.M., Deugnier M.A., Tlouzeau S., Thiery J.P., Glukhova M.A. Perturbation of β1-integrin function in involuting mammary gland results in premature dedifferentiation of secretory epithelial cells. Mol. Biol. Cell. 13:2002;3521-3531
12. Fassler R., Meyer M. Consequences of lack of β1 integrin gene expression in mice. Genes Dev. 9:1995;1896-1908
13. Feltri M.L., Graus Porta D., Previtali S.C., Nodari A., Migliavacca B., Cassetti A., Littlewood-Evans A., Reichardt L.F., Messing A., Quattrini A., et al. Conditional disruption of β1 integrin in Schwann cells impedes interactions with axons. J. Cell Biol. 156:2002;199-209
14. Gabarra-Niecko V., Schaller M.D., Dunty J.M. FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev. 22:2003;359-374
15. Graff J.R., Deddens J.A., Konicek B.W., Colligan B.M., Hurst B.M., Carter H.W., Carter J.H. Integrin-linked kinase expression increases with prostate tumor grade. Clin. Cancer Res. 7:2001;1987-1991
16. Graus-Porta D., Blaess S., Senften M., Littlewood-Evans A., Damsky C., Huang Z., Orban P., Klein R., Schittny J.C., Muller U. β1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron. 31:2001;367-379
17. Guy C.T., Cardiff R.D., Muller W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene. A transgenic mouse model for metastatic disease Mol. Cell. Biol. 12:1992;954-961
18. Guy C.T., Muthuswamy S.K., Cardiff R.D., Soriano P., Muller W.J. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev. 8:1994;23-32
19. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70
20. Hanks S.K., Polte T.R. Signaling through focal adhesion kinase. Bioessays. 19:1997;137-145
21. Howe A., Aplin A.E., Alahari S.K., Juliano R.L. Integrin signaling and cell growth control. Curr. Opin. Cell Biol. 10:1998;220-231
22. Ichaso N., Dilworth S.M. Cell transformation by the middle T-antigen of polyoma virus. Oncogene. 20:2001;7908-7916
23. Kenny P.A., Bissell M.J. Tumor reversion. Correction of malignant behavior by microenvironmental cues Int. J. Cancer. 107:2003;688-695
24. Kornberg L., Earp H.S., Parsons J.T., Schaller M., Juliano R.L. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J. Biol. Chem. 267:1992;23439-23442
25. Lin E.Y., Jones J.G., Li P., Zhu L., Whitney K.D., Muller W.J., Pollard J.W. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163:2003;2113-2126
26. Maglione J.E., Moghanaki D., Young L.J., Manner C.K., Ellies L.G., Joseph S.O., Nicholson B., Cardiff R.D., MacLeod C.L. Transgenic polyoma middle-T mice model premalignant mammary disease. Cancer Res. 61:2001;8298-8305
27. Marotta A., Tan C., Gray V., Malik S., Gallinger S., Sanghera J., Dupuis B., Owen D., Dedhar S., Salh B. Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. Oncogene. 20:2001;6250-6257
28. McLean G.W., Brown K., Arbuckle M.I., Wyke A.W., Pikkarainen T., Ruoslahti E., Frame M.C. Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis. Cancer Res. 61:2001;8385-8389
29. Moody S.E., Sarkisian C.J., Hahn K.T., Gunther E.J., Pickup S., Dugan K.D., Innocent N., Cardiff R.D., Schnall M.D., Chodosh L.A. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell. 2:2002;451-461
30. Moro L., Venturino M., Bozzo C., Silengo L., Altruda F., Beguinot L., Tarone G., Defilippi P. Integrins induce activation of EGF receptor. Role in MAP kinase induction and adhesion-dependent cell survival EMBO J. 17:1998;6622-6632
31. Oktay M., Wary K.K., Dans M., Birge R.B., Giancotti F.G. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle. J. Cell Biol. 145:1999;1461-1469
32. Oktay M.H., Oktay K., Hamele-Bena D., Buyuk A., Koss L.G. Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Hum. Pathol. 34:2003;240-245
33. Owens L.V., Xu L., Craven R.J., Dent G.A., Weiner T.M., Kornberg L., Liu E.T., Cance W.G. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55:1995;2752-2755
34. Radeva G., Petrocelli T., Behrend E., Leung-Hagesteijn C., Filmus J., Slingerland J., Dedhar S. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J. Biol. Chem. 272:1997;13937-13944
35. Ronnov-Jessen L., Petersen O.W., Bissell M.J. Cellular changes involved in conversion of normal to malignant breast. Importance of the stromal reaction Physiol. Rev. 76:1996;69-125
36. Saulnier R., Bhardwaj B., Klassen J., Leopold D., Rahimi N., Tremblay E., Mosher D., Elliott B. Fibronectin fibrils and growth factors stimulate anchorage-independent growth of a murine mammary carcinoma. Exp. Cell Res. 222:1996;360-369
37. Shekhar M.P., Pauley R., Heppner G. Host microenvironment in breast cancer development. Extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast Breast Cancer Res. 5:2003;130-135
38. Sieg D.J., Hauck C.R., Schlaepfer D.D. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J. Cell Sci. 112:1999;2677-2691
39. Sieg D.J., Hauck C.R., Ilic D., Klingbeil C.K., Schaefer E., Damsky C.H., Schlaepfer D.D. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2:2000;249-256
40. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:1999;70-71
41. Tan C., Cruet-Hennequart S., Troussard A., Fazli L., Costello P., Sutton K., Wheeler J., Gleave M., Sanghera J., Dedhar S. Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell. 5:2004;79-90
42. Terpstra L., Prud'homme J., Arabian A., Takeda S., Karsenty G., Dedhar S., St-Arnaud R. Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. J. Cell Biol. 162:2003;139-148
43. Troussard A.A., Mawji N.M., Ong C., Mui A., St.-Arnaud R., Dedhar S. Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J. Biol. Chem. 278:2003;22374-22378
44. Wang F., Weaver V.M., Petersen O.W., Larabell C.A., Dedhar S., Briand P., Lupu R., Bissell M.J. Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures. A different perspective in epithelial biology Proc. Natl. Acad. Sci. USA. 95:1998;14821-14826
45. Wang F., Hansen R.K., Radisky D., Yoneda T., Barcellos-Hoff M.H., Petersen O.W., Turley E.A., Bissell M.J. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J. Natl. Cancer Inst. 94:2002;1494-1503
46. Weaver V.M., Petersen O.W., Wang F., Larabell C.A., Briand P., Damsky C., Bissell M.J. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137:1997;231-245
47. Webb D.J., Donais K., Whitmore L.A., Thomas S.M., Turner C.E., Parsons J.T., Horwitz A.F. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell Biol. 6:2004;154-161
48. Webster M.A., Hutchinson J.N., Rauh M.J., Muthuswamy S.K., Anton M., Tortorice C.G., Cardiff R.D., Graham F.L., Hassell J.A., Muller W.J. Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol. 18:1998;2344-2359
49. White D.E., Cardiff R.D., Dedhar S., Muller W.J. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene. 20:2001;7064-7072
50. Wiseman B.S., Werb Z. Stromal effects on mammary gland development and breast cancer. Science. 296:2002;1046-1049
51. Xing Z., Chen H.C., Nowlen J.K., Taylor S.J., Shalloway D., Guan J.L. Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. Mol. Biol. Cell. 5:1994;413-421
52. Zhao J.H., Reiske H., Guan J.L. Regulation of the cell cycle by focal adhesion kinase. J. Cell Biol. 143:1998;1997-2008